Voloridge Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
DTC
BCM
MC
Voloridge Investment Management's SWTX Position: Q4 2024 in Review
Voloridge Investment Management sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 86,599 shares — an estimated $2.77M sold.
Voloridge Investment Management first reported a position in SWTX in Q4 2020 and held it in 16 quarters. The position peaked at $18.3M in Q4 2023. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.
- Voloridge Investment Management reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
- Voloridge Investment Management sold 86,599 SpringWorks Therapeutics shares in Q4 2024, an estimated $2.77M.
- Voloridge Investment Management first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 16 quarters.
- Voloridge Investment Management's SpringWorks Therapeutics position peaked at $18.3M in Q4 2023.
- 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.
Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.